MORE►
de-extinction
The Colossal Foundation is partnering with the University of Tasmania on an initiative to fight a facial cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s. [Photo: Colossal Foundation]
Colossal Foundation Partners with the University of Tasmania to ‘Give Tasmanian Devils a Fighting Chance’
by Sandra Engelland | Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
by Sandra Engelland |
Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
MORE►
by Lance Murray |
Nov 13, 2025
The Bolson tortoise is North America's largest and rarest tortoise species. Its population has grown from 23 adults to over 800 individuals through captive breeding, with over 150 juveniles released since 2021 showing 80%+ survival rates.
MORE►
by Lance Murray |
Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE►
![The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]](https://s24806.pcdn.co/wp-content/uploads/2025/07/Colossal-Moa-940x436.jpg)
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by Quincy Preston | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
by Lance Murray |
Dec 17, 2024
“Helping to stop the spread of chytrid is a necessity to ensure healthy ecosystems globally,” said Colossal Foundation Director Matt James. “This isn’t optional. We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come."
MORE►
by Lance Murray |
Oct 1, 2024
The North Texas-based foundation aims to fight the "extinction crisis" with initiatives including Colossal Biovault—"the world's largest distributed biobanking initiative"—and an array of new efforts to both preserve and "de-extinct" wildlife.
MORE►
by Lance Murray |
Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
MORE►
[Image sources: James Reed, Matt Petit/A.M.P.A.S. via Getty Image/Business Wire; Colossal, Dallas Innovates]
Director of Oscar-Winning ‘My Octopus Teacher’ To Make a Docuseries on Dallas-Based Colossal Biosciences
by Lance Murray | Feb 21, 2024
Colossal Biosciences and production partner Teton Ridge Entertainment have signed with James Reed, director of the Oscar-winning Netflix documentary "My Octopus Teacher," and his company Underdog Films, to produce the docuseries.
MORE►
by Lance Murray |
Feb 2, 2024
Veteran marketing executive Emily Castel has joined Colossal Bioscience, the world’s first de-extinction company, as its first chief marketing officer, bringing her global entertainment and consumer brand experience to Colossal where she will lead global efforts to scale the company’s brand, experiences, consumer products, and emerging media properties....
MORE►
by Lance Murray |
Nov 9, 2023
Save the Elephants will deploy a small fleet of drones equipped with high resolution and infrared cameras to capture elephant behavioral data, which will then be processed by Colossal’s machine learning core to develop algorithms that will label elephants and automatically identify individual and collective social behavior.
MORE►
by Lance Murray |
May 19, 2023
Last year, the partnership announced a near complete sequence of the Asian elephant genome. Colossal and VGP said the sequencing work is part of a long-term effort to ensure the survival of elephant species in the face of climate change, deforestation, and disease.
MORE►
The Tasmanian tiger went extinct due to human hunting nearly 100 years ago. Now Dallas-based Colossal Biosciences aims to bring it back with the help of "marsupial biobanking." [Image: Colossal Biosciences]
Dallas-Based Colossal Is ‘De-Extincting’ the Tasmanian Tiger
by David Seeley | Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
